Most studies have focused on the role of total GSK-3 or GSK-3β [25–27], but recent studies implicated the oncogenic role of GSK-3α in acute myeloid leukemia (AML) [28], prostate cancer [29], and pancreatic cancer [30]. This evidence concerns the gene GSK3A and familial pancreatic carcinoma.